Working Collaboratively, Growing Together

Biortus is a leading world-class contract research organization that provides a one-stop service of gene synthesis to structure determination. Since 2009, Biortus has partnered worldwide with numerous research institutions, pharmaceutical and biotechnology companies - consistently providing high-quality custom proteins for all stages of biomedical research.

In addition to Custom Protein Generation, our subsidiaries,  Biortus USA now provides rapidly available crystallography-grade proteins in the Biortus Protein Catalogue to better serve the global life science industry. Many of these proteins have been crystallized and/or structurally elucidated using our in-house X-ray and Cryo-EM facilities. 

The Biortus Protein Catalogue currently comprises of over 1,900 independent drug targets, consisting of Membrane Proteins, Kinases, ubiquitin-proteasome enzymes (DUBS and E3 Ligases), CDKs (cyclin and cyclin dependent kinases) and more, covering a wide range of therapeutic areas. All protein samples are individually packaged with detailed quality control reports of protein solubility, purity, and stability with optional reports on functional activity based on client needs.